Biofrontera (BFRI) Non-Current Assets (2020 - 2025)

Biofrontera's (BFRI) quarterly Non-Current Assets came in at $10.5 million in Q4 2025, up 648.11% year-on-year from $1.4 million in Q4 2024, and up 946.01% quarter-over-quarter from $1.0 million in Q3 2025.

Biofrontera (BFRI) Non-Current Assets (2020 - 2025) Analysis & Trends

Biofrontera's Non-Current Assets history runs 6 years deep, the most recent figure standing at $10.5 million for Q4 2025.

  • On a quarterly basis, Non-Current Assets rose 648.11% year-over-year to $10.5 million in Q4 2025; TTM through Dec 2025 was $14.1 million, a 22.22% increase from a year earlier, with the FY2025 full-year figure at $10.5 million, up 648.11% from the prior year.
  • Non-Current Assets climbed to $10.5 million in Q4 2025 per BFRI's latest filing, from $1.0 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $10.5 million in Q4 2025 and bottomed at -$46.4 million in Q4 2021.
  • The 5-year median for Non-Current Assets is $4.5 million (2023), against an average of $1.5 million.
  • Across the five-year window, Non-Current Assets slumped 1117.38% in 2021 and surged 648.11% in 2025, its largest moves.
  • Year by year, Non-Current Assets stood at -$46.4 million in 2021, then surged by 116.68% to $7.7 million in 2022, then tumbled by 37.28% to $4.9 million in 2023, then plunged by 71.16% to $1.4 million in 2024, then jumped by 648.11% to $10.5 million in 2025.
  • Per Business Quant, the three latest BFRI Non-Current Assets figures stand at $10.5 million (Q4 2025), $1.0 million (Q3 2025), and $1.3 million (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 36.78 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 26.33 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 8.68 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 79.20 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 3.84 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 15.70 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 25.92 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 2.47 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 9.64 Bn
10 Biofrontera 12.70 Mn 6.29 Mn 14.09 Mn 10.48 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 10.48 Mn
Sep 30, 2025 1.00 Mn
Jun 30, 2025 1.33 Mn
Mar 31, 2025 1.26 Mn
Dec 31, 2024 1.40 Mn
Sep 30, 2024 1.59 Mn
Jun 30, 2024 4.10 Mn
Mar 31, 2024 4.42 Mn
Dec 31, 2023 4.86 Mn
Sep 30, 2023 4.49 Mn
Mar 31, 2023 4.74 Mn
Dec 31, 2022 7.74 Mn
Sep 30, 2022 6.57 Mn
Jun 30, 2022 6.65 Mn
Mar 31, 2022 6.67 Mn
Dec 31, 2021 -46.41 Mn
Sep 30, 2021 5.22 Mn
Dec 31, 2020 4.56 Mn